Skip to main content

Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege.

Publication ,  Journal Article
Lorrey, SJ; Waibl Polania, J; Wachsmuth, LP; Hoyt-Miggelbrink, A; Tritz, ZP; Edwards, R; Wolf, DM; Johnson, AJ; Fecci, PE; Ayasoufi, K
Published in: Neurooncol Adv
2023

BACKGROUND: The nervous and immune systems interact in a reciprocal manner, both under physiologic and pathologic conditions. Literature spanning various CNS pathologies including brain tumors, stroke, traumatic brain injury and de-myelinating diseases describes a number of associated systemic immunologic changes, particularly in the T-cell compartment. These immunologic changes include severe T-cell lymphopenia, lymphoid organ contraction, and T-cell sequestration within the bone marrow. METHODS: We performed an in-depth systematic review of the literature and discussed pathologies that involve brain insults and systemic immune derangements. CONCLUSIONS: In this review, we propose that the same immunologic changes hereafter termed 'systemic immune derangements', are present across CNS pathologies and may represent a novel, systemic mechanism of immune privilege for the CNS. We further demonstrate that systemic immune derangements are transient when associated with isolated insults such as stroke and TBI but persist in the setting of chronic CNS insults such as brain tumors. Systemic immune derangements have vast implications for informed treatment modalities and outcomes of various neurologic pathologies.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurooncol Adv

DOI

EISSN

2632-2498

Publication Date

2023

Volume

5

Issue

1

Start / End Page

vdad035

Location

England
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lorrey, S. J., Waibl Polania, J., Wachsmuth, L. P., Hoyt-Miggelbrink, A., Tritz, Z. P., Edwards, R., … Ayasoufi, K. (2023). Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege. Neurooncol Adv, 5(1), vdad035. https://doi.org/10.1093/noajnl/vdad035
Lorrey, Selena J., Jessica Waibl Polania, Lucas P. Wachsmuth, Alexandra Hoyt-Miggelbrink, Zachariah P. Tritz, Ryan Edwards, Delaney M. Wolf, Aaron J. Johnson, Peter E. Fecci, and Katayoun Ayasoufi. “Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege.Neurooncol Adv 5, no. 1 (2023): vdad035. https://doi.org/10.1093/noajnl/vdad035.
Lorrey SJ, Waibl Polania J, Wachsmuth LP, Hoyt-Miggelbrink A, Tritz ZP, Edwards R, et al. Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege. Neurooncol Adv. 2023;5(1):vdad035.
Lorrey, Selena J., et al. “Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege.Neurooncol Adv, vol. 5, no. 1, 2023, p. vdad035. Pubmed, doi:10.1093/noajnl/vdad035.
Lorrey SJ, Waibl Polania J, Wachsmuth LP, Hoyt-Miggelbrink A, Tritz ZP, Edwards R, Wolf DM, Johnson AJ, Fecci PE, Ayasoufi K. Systemic immune derangements are shared across various CNS pathologies and reflect novel mechanisms of immune privilege. Neurooncol Adv. 2023;5(1):vdad035.

Published In

Neurooncol Adv

DOI

EISSN

2632-2498

Publication Date

2023

Volume

5

Issue

1

Start / End Page

vdad035

Location

England